Geode Capital Management’s Orphazyme A/S ORPH Stock Holding History

Geode Capital Management’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-177,074	Closed	-$426K	–	5040
2021 Q4	$426K	Buy	177,074 +151,434	+591%	+$535K	﹤0.01%	4132
2021 Q3	$105K	Buy	+25,640	New	+$132K	﹤0.01%	4659

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Geode Capital Management's ORPH Position: Q1 2022 in Review

Geode Capital Management sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 177,074 shares — an estimated $426K sold.

Geode Capital Management first reported a position in ORPH in Q3 2021 and held it in 2 quarters. The position peaked at $426K in Q4 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Geode Capital Management reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Geode Capital Management sold 177,074 Orphazyme A/S shares in Q1 2022, an estimated $426K.
Geode Capital Management first reported a position in Orphazyme A/S in Q3 2021 and held it in 2 quarters.
Geode Capital Management's Orphazyme A/S position peaked at $426K in Q4 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.